Evidence map›Paper›PMID 25139904›Full record

ArticlemBio2014

Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.

Sudha R Somarajan, Fadi Al-Asadi, Kumaraguruparan Ramasamy, Lavanya Pandranki, Joel B Baseman, T R Kannan

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Advances in adhesion-related pathogenesis inFrontiers in microbiology · 2025
    Review
  9. The Immune Modulatory Role of Surfactants inJournal of inflammation research · 2025
    Review
  10. Journal of medical microbiology · 2024
    Review
  11. Annexin A2: A Double-Edged Sword in Pathogen Infection.Pathogens (Basel, Switzerland) · 2024
    Review
  12. Review
  13. Article
  14. PathogenicFrontiers in microbiology · 2022
    Article
  15. Article
  16. Annexin A2 regulatesFrontiers in immunology · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sudha R SomarajanDepartment of Microbiology and Immunology, Center for Airway Inflammation Research, South Texas Research Facility, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Fadi Al-AsadiDepartment of Microbiology and Immunology, Center for Airway Inflammation Research, South Texas Research Facility, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Kumaraguruparan RamasamyDepartment of Microbiology and Immunology, Center for Airway Inflammation Research, South Texas Research Facility, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Lavanya PandrankiDepartment of Microbiology and Immunology, Center for Airway Inflammation Research, South Texas Research Facility, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Joel B BasemanDepartment of Microbiology and Immunology, Center for Airway Inflammation Research, South Texas Research Facility, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA baseman@uthscsa.edu Kannan@uthscsa.edu.
T R KannanDepartment of Microbiology and Immunology, Center for Airway Inflammation Research, South Texas Research Facility, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA baseman@uthscsa.edu Kannan@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

The role of CARDS toxin in genesis and exacerbation of allergic inflammationU19AI070412 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BASEMAN, JOEL BARRY · 2006 to 2015
$19.7M
NIAID NIH HHS U19 AI070412
6 · The paper itself

Abstract

unlabelledMycoplasma pneumoniae synthesizes a novel human surfactant protein A (SP-A)-binding cytotoxin, designated community-acquired respiratory distress syndrome (CARDS) toxin, that exhibits ADP-ribosylating and vacuolating activities in mammalian cells and is directly linked to a range of acute and chronic airway diseases, including asthma. In our attempt to detect additional CARDS toxin-binding proteins, we subjected the membrane fraction of human A549 airway cells to affinity chromatography using recombinant CARDS toxin as bait. A 36-kDa A549 cell membrane protein bound to CARDS toxin and was identified by time of flight (TOF) mass spectroscopy as annexin A2 (AnxA2) and verified by immunoblotting with anti-AnxA2 monoclonal antibody. Dose-dependent binding of CARDS toxin to recombinant AnxA2 reinforced the specificity of the interaction, and further studies revealed that the carboxy terminus of CARDS toxin mediated binding to AnxA2. In addition, pretreatment of viable A549 cells with anti-AnxA2 monoclonal antibody or AnxA2 small interfering RNA (siRNA) reduced toxin binding and internalization. Immunofluorescence analysis of CARDS toxin-treated A549 cells demonstrated the colocalization of CARDS toxin with cell surface-associated AnxA2 upon initial binding and with intracellular AnxA2 following toxin internalization. HepG2 cells, which express low levels of AnxA2, were transfected with a plasmid expressing AnxA2 protein, resulting in enhanced binding of CARDS toxin and increased vacuolization. In addition, NCI-H441 cells, which express both AnxA2 and SP-A, upon AnxA2 siRNA transfection, showed decreased binding and subsequent vacuolization. These results indicate that CARDS toxin recognizes AnxA2 as a functional receptor, leading to CARDS toxin-induced changes in mammalian cells. IMPORTANCE: Host cell susceptibility to bacterial toxins is usually determined by the presence and abundance of appropriate receptors, which provides a molecular basis for toxin target cell specificities. To perform its ADP-ribosylating and vacuolating activities, community-acquired respiratory distress syndrome (CARDS) toxin must bind to host cell surfaces via receptor-mediated events in order to be internalized and trafficked effectively. Earlier, we reported the binding of CARDS toxin to surfactant protein A (SP-A), and here we show how CARDS toxin uses an alternative receptor to execute its pathogenic properties. CARDS toxin binds selectively to annexin A2 (AnxA2), which exists both on the cell surface and intracellularly. Since AnxA2 regulates membrane dynamics at early stages of endocytosis and trafficking, it serves as a distinct receptor for CARDS toxin binding and internalization and enhances CARDS toxin-induced vacuolization in mammalian cells.

Indexed as

AnimalsAnnexin A2Antibodies, MonoclonalBacterial ProteinsBacterial ToxinsCell Line, TumorEndocytosisFluorescent Antibody TechniqueHep G2 CellsHumansMycoplasma pneumoniaeProtein BindingRespiratory Distress SyndromeRNA, Small InterferingSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationVacuolesAnnexin A2Antibodies, MonoclonalANXA2 protein, humanBacterial ProteinsBacterial ToxinsCARDS toxin, Mycoplasma pneumoniaeRNA, Small Interfering

Identifiers

PMID25139904
PMCPMC4147866
OpenAlexW2048167442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.